BRIEF-Advaxis?
AXAL Receives Fast Track Designation by FDA
* Advaxis'
AXAL Receives Fast Track Designation by the FDAas adjuvant therapy for high-risk locally advanced cervicalcancer patientsSource text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)